BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,000 | 0.0% | 336 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $15,000 | -70.6% | 336 | -76.8% | 0.00% | -50.0% |
| Q1 2019 | $51,000 | 0.0% | 1,449 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | +37.8% | 1,449 | +46.7% | 0.00% | 0.0% |
| Q3 2018 | $37,000 | -9.8% | 988 | -6.1% | 0.00% | -50.0% |
| Q2 2018 | $41,000 | -24.1% | 1,052 | -49.7% | 0.00% | – |
| Q1 2018 | $54,000 | +145.5% | 2,093 | +150.7% | 0.00% | -100.0% |
| Q4 2017 | $22,000 | -63.9% | 835 | +62.1% | 0.00% | -75.0% |
| Q3 2017 | $61,000 | – | 515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |